Previous Article | Next Article ![]()
Infection and Immunity, January 2003, p. 242-253, Vol. 71, No. 1
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.1.242-253.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Microbial Pathogenesis Unit,1 Hormone and Metabolic Research Unit, Christian de Duve Institute of Cellular PathologyFaculté de Médecine, Université Catholique de Louvain, B1200 Brussels, Belgium,3 Biozentrum der Universität Basel, CH 4056 Basel, Switzerland,2 Unité de Pathogénie Microbienne Moléculaire, Institut Pasteur, 75724 Paris, France4
Received 11 June 2002/ Returned for modification 31 July 2002/ Accepted 23 October 2002
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Y. enterocolitica bacteria enter the gastrointestinal tract after ingestion of contaminated food or water. They cross the intestinal epithelium through M cells and reach the underlying lymphoid tissue, where they multiply (13). Pathogenic Y. enterocolitica strains are classified into a series of biotypes (1B to 5) on the basis of metabolic properties and epidemiological observations (60). Most of the Y. enterocolitica strains obtained from human clinical material worldwide belong to biotype 4, serotype O:3 (22, 25). In contrast, strains from biotype 1B are usually isolated from patients in the United States (9, 56), although they have also been found recently in Europe and Asia (18, 27). They are lethal for mice orally infected while bacteria from the other biotypes are not. This high virulence can be explained by the presence, in addition to the pYV plasmid, of a pathogenicity island encoding an iron uptake system (4, 44).
Recently, genes encoding a second TTSS, called Ysa, have been characterized on the chromosome of biotype 1B Y. enterocolitica strains 8081 and A127/90 and detected on the chromosome of the nine biotype 1B strains that have been tested previously (11, 14). The ysa locus is not present in the low-virulence strains of Y. enterocolitica (11). According to gene sequence and organization, the Ysa system is closely related to the Mxi-Spa TTSS of Shigella flexneri and to the SPI-1-encoded TTSS of Salmonella enterica (11).
S. flexneri is an enteropathogenic bacterium with a lifestyle different from that of Y. enterocolitica. When S. flexneri bacteria reach the colon, they are transported through the epithelial barrier by way of M cells (46, 59). They infect the resident macrophages and induce cell death (65). S. flexneri bacteria released from killed macrophages enter enterocytes from the basolateral surface by inducing membrane ruffling and macropinocytosis (39). Following entry, the membrane of the vacuole that contains bacteria is rapidly disrupted and bacteria escape into the cytoplasm (48), where they multiply (1, 26). These features are associated with the presence of the Mxi-Spa TTS apparatus; the effector proteins IpaA, -B, -C, and -D; IpgB and IpgD; and the chaperones IpgC, IpgE, and Spa15 (3, 41, 50, 51). The main effectors of entry into epithelial cells are IpaB and IpaC (29), which are also needed for escape from the phagosome (17, 64) and for lysis of the membrane surrounding bacteria during the process of cell-to-cell dissemination (40). In addition, IpaB is responsible for the induction of the apoptotic process in macrophages (5, 65). Before secretion, IpaB and IpaC associate independently with the chaperone IpgC (31).
Products of the ysa locus called sycB, yspB, yspC, and yspD share limited sequence similarity to the products of sicA, sipB, sipC, and sipD from the Salmonella SPI-1 TTSS and to the products of ipgC, ipaB, ipaC, and ipaD from Shigella Mxi-Spa TTSS.
In this study we characterize the products of the sycB, yspB, yspC, yspD, and yspA genes, and we identify YspA, YspB, YspC, and YspD as secreted proteins and SycB as a chaperone for YspB and YspC. We also show that under low-temperature and high-salt (LTHS) conditions the pYV-encoded YopE protein is secreted by the Ysa apparatus together with the Ysp proteins. Although YspC and probably YspB proteins could be secreted by the Shigella Mxi-Spa apparatus, we did not observe any functional complementation of ipaB or ipaC mutants. Additionally, they could not form detectable pores in eukaryotic target cells and could not substitute for YopB and YopD for translocation of Yop effectors.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
(ii) Construction of pBluescript SK(-)-derived recombinant plasmids. The sycB, sycB-yspB, or sycB-yspB-yspC genes were PCR amplified with Cos23 DNA as a template with amplimers Mipa 1251 (5'-CGCTCTAGAATAAAGGAGAGTATATGAACCAG-3') and Mipa 1198 (5'-CCGCTCGAGTTATCCTTCTGCTGG-3') or Mipa 1184 (5'-CCGCTCGAGTTAAGCAAAACTGCTTTT-3') or Mipa 1186 (5'-CCGCTCGAGTTAACCCTTAACAATGGC-3') and cloned into the XbaI-XhoI sites of pBluescript SK(-), yielding plasmids pBF25, pBF26, and pBF27, respectively. For construction of pBF29, pBF27 was digested with PstI and NruI, resulting in a 969-bp in-frame deletion in yspB. The linear DNA fragment was treated with T4 DNA polymerase and blunt end ligated to give pBF29.
(iii) Construction of pGEX-6P-1-derived recombinant plasmids.
The sycB-yspB(His)6 genes were PCR amplified with pBF17 DNA as template with oligonucleotides Mipa 1197 (5'-GCGGATCCAACCAGAAACATG-3') and Mipa 1200 (5'-CCGCTCGAGTTAATGATGATGATGATG-3') and cloned into BamHI-XhoI sites of pGEX-6P-1 vector, giving the pBF23 plasmid encoding glutathione S-transferase (GST)-SycB YspB-(His)6. When we sequenced our recombinant clones, we observed that one clone had suffered a point mutation (GAA
TAA) in codon 21 of sycB, giving the truncated gst-sycB1-21 gene. This clone encoding GST-SycB1-21 YspB-(His)6 has been named pBF24. The sycB, yspB, and yspC genes were PCR amplified with Cos23 DNA as a template with amplimers Mipa 1197 (5'-GCGGATCCAACCAGAAACATG-3') and Mipa 1198 (5'-CCGCTCGAGTTATCCTTCTGCTGG-3'), Mipa 1183 (5'-GCGGATCCGAACAGGAGAAACATCACC-3') and Mipa 1184 (5'-CCGCTCGAGTTAAGCAAAACTGCTTTT-3'), and Mipa 1185 (5'-GCGGATCCACCACTATTCAACAAGCC-3') and Mipa 1186 (5'-CCGCTCGAGTTAACCCTTAACAATGGC-3') and cloned into BamHI-XhoI sites of pGEX-6P-1 vector, giving pBF20, pBF21, and pBF22, respectively. A 1,062-bp segment of yspD and surrounding bases was amplified by PCR with the oligonucleotides Mipa 1257 (5'-CGCGGATCCACAACAGCGATTATTTCAC-3') and Mipa 1258 (5'-CCGGAATTCTGACCATAGCCCATA-3') and cloned in the BamHI-EcoRI sites of pGEX-4T-3 (Amersham Biosciences), giving pPT14. The plasmids used in this study are listed in Table 1.
ysaN, yspA, yspB, and ysaD mutagenesis. A 399-bp segment of yspB was amplified by PCR with oligonucleotides Mipa 922 (5'-ATGTTGGCCGATCAGGAC-3') and Mipa 923 (5'-TTAGGGCATACCAACCG-3') and blunt end cloned in the EcoRV site of suicide vector pKNG90A (23), giving pBF19. A 402-bp segment of ysaN was amplified by PCR with oligonucleotides Mipa 841 (5'-GCGAAGAGGAATCCGACCC-3') and Mipa 842 (5'-CGCCGTTGTGTGAGGCTC-3') and blunt end cloned in the EcoRV site of pKNG90A suicide vector, giving pFM2. A 510-bp segment of yspD was amplified by PCR from pPT14 with the oligonucleotides Mipa 1259 (5'-GCTCTAGACGAAGTGACGACAGCTA-3') and Mipa 1260 (5'-GCTCTAGATCTCTGTGATGATGGGAG-3') and cloned in the XbaI site of the suicide vector pPT7, leading to the pPT15 yspD mutator. A 501-bp segment of yspA was amplified by PCR with the oligonucleotides Mipa 1261 (5'-GCTCTAATGCCTGATATCACGGCA-3') and Mipa 1262 (5'-GCTCTAGATCACTCAATCTCTGTGGGT-3') and cloned in the XbaI site of pPT7, leading to the pPT16 yspA mutator. The suicide plasmids were introduced into Y. enterocolitica strain 8081 by electroporation. Transformants were selected for their ability to grow on a medium containing streptomycin. The insertion of the suicide plasmids was checked by PCR with the Expand long template system (Boehringer Mannheim GmbH).
Analysis of proteins from culture supernatants. Y. enterocolitica or S. flexneri was harvested by centrifugation at 2,500 x g for 15 min. Proteins from the culture supernatant were precipitated with trichloroacetic acid (TCA) at a 10% (wt/vol) final concentration and resuspended in Laemmli buffer at concentrations indicated in the figure legends. For Congo red-induced secretion of S. flexneri, the bacterial pellet of a 4-h culture was resuspended in phosphate-buffered saline (PBS). Bacteria were then incubated in the presence of 7 µg of Congo red/ml for 30 min at 37°C. Samples were centrifuged for 10 min at 14,000 x g, and proteins present in the supernatant were TCA precipitated and resuspended in Laemmli sample buffer. Proteins from the crude extracts of E. coli, Y. enterocolitica, or S. flexneri were resuspended in Laemmli buffer, boiled for 5 min at 95°C, and loaded on sodium dodecyl sulfate (SDS)-12% (wt/vol) polyacrylamide gels (SDS-polyacrylamide gel electrophoresis ). After electrophoresis, proteins were either stained with Coomassie brilliant blue or transferred to a nitrocellulose membrane. Immunoblotting was carried out with anti-GST polyclonal antibody (Amersham Pharmacia Biotech) and anti-His (C-terminal) monoclonal antibody (Invitrogen) as recommended by the manufacturer. Anti-YspC polyclonal antibody was used at a dilution of 1:5,000, and anti-YspD polyclonal antibody was used at a dilution of 1:2,000. YopE and SycE were detected with polyclonal antibodies used at dilutions of 1:15,000 and 1:500, respectively. Supersignal chemiluminescent substrates (Pierce) were used for chemiluminescence detection. The production and purification of YspC and YspD were performed according to the protocol supplied by Amersham Pharmacia Biotech. YspC and YspD were eluted by Prescission protease cleavage. One milligram of the purified YspC or YspD was used to immunize a rabbit.
SycB, YspB, and YspC binding and stabilization experiments. GST-SycB plus YspB-(His)6 and GST-SycB1-21 plus YspB-(His)6 production was induced with 0.5 mM IPTG when the optical density at 600 nm reached 0.5, and the mixture was incubated further for 80 min. Bacteria (5 x 108) were centrifuged at 22,000 x g for 5 min. The bacterial pellet was resuspended in 1 ml of PBS (pH 7.4) containing 0.5 mg of 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS) per ml and sonicated. The soluble fraction was recovered by a 15-min centrifugation step (14,000 x g) at 4°C. For coimmunoprecipitation, polyclonal anti-GST antibody (Amersham Biosciences) was added at a 1:200 dilution. After 30 min of gentle rocking at 4°C, the immunocomplexes were harvested by addition of 50 µl of protein A-Sepharose CL-4B (50% slurry in PBS). The complex was then gently rocked overnight at 4°C, collected by centrifugation at 600 x g, washed five times in PBS, and eluted from the protein A-Sepharose CL-4B by being boiled in sample buffer. The eluted proteins were analyzed by SDS-PAGE.
For GST affinity-binding experiments, 50 µl of glutathione-Sepharose CL-4B (50% slurry in PBS) was added to the soluble fraction and incubated overnight with gentle rocking at 4°C. The washing and elution steps were the same as for coimmunoprecipitation. For GST-SycB-YspC binding, GST-SycB production was induced with 0.5 mM IPTG for 80 min. Bacteria (5 x 108) were centrifuged at 15,000 rpm for 5 min. The bacterial pellet was resuspended in 1 ml of PBS (pH 7.4)-0.5 mg of CHAPS per ml and sonicated. The soluble fraction was recovered by a 15-min centrifugation step (14,000 x g) at 4°C. Twenty micrograms of purified YspC was added to the soluble fraction and incubated for 1 h at 4°C. Fifty microliters of glutathione-Sepharose CL-4B (50% slurry in PBS) was added to the soluble fraction and incubated overnight with gentle rocking at 4°C. The washing and elution steps were the same as described above.
For YspB stabilization experiments, GST-SycB + YspB-(His)6 and GST-SycB1-21 + YspB-(His)6 production was induced as described above. After 80 min, protein synthesis was stopped by adding 20 µg of chloramphenicol per ml to the culture and an initial 500-µl aliquot was taken. Similar aliquots were then taken every 40 min. The content of 5 x 108 bacteria was analyzed by SDS-PAGE.
BCECF release assay. J774 mouse monocyte macrophage cell lines were grown routinely in RPMI 1640 medium (Gibco) supplemented with 2 mM L-glutamine (Seromed), 10% (vol/vol) fetal bovine serum (Gibco), 100 U of penicillin (Gibco) per ml, and 100 µg of streptomycin per ml at 37°C under 5% CO2. At 20 h before infection, cells (4 x 105 cells per ml) were seeded in 24-well tissue culture plates (1 ml per well). Just before infection, cells were washed twice with 1 ml of PBS and labeled by incubation for 20 min at 37°C with 10 µM BCECF-AM [2',7'-bis-(2-carboxyethyl)-5-(and -6)-carboxyfluorescein, acetoxymethyl ester; Molecular Probes]. Cells were then washed twice with RPMI with 2 mM L-glutamine (Seromed) and incubated further with 1 ml of the same medium containing bacteria. Y. enterocolitica strains were grown for 90 min at room temperature in BHI-Ox and then transferred to 37°C for 2 h to induce Yop synthesis. Bacteria were then washed and resuspended in prewarmed saline. Cells were infected for 1 h at a multiplicity of infection of 125. To facilitate contact between bacteria and cells, the plates were centrifuged for 5 min at 400 x g. After 1 h of infection, the macrophages were pelleted by centrifugation at 250 x g for 5 min. Aliquots of the cell culture supernatant (150 µl) were transferred into a 96-multiwell plate, and fluorescence was measured with a spectrofluorimeter (Perkin-Elmer HTS 7000+) with an excitation wavelength of 490 nm and a reading wavelength of 520 nm. The amount of BCECF released by cells treated with Triton X-100 (0.1%) for 1 h was taken as 100% of release. The percentage of lysis was calculated by the following formula: percent lysis = (sample uninfected)/(Triton uninfected).
YopE injection. The J774 cells were grown routinely as indicated above. Twenty hours before infection, six-well plates were seeded with 5 x 105 cells per well. Prior to infections, freshly grown Y. enterocolitica strains were preincubated at room temperature for 2 h and at 37°C for 30 min, washed in RPMI, and added to the cells at a multiplicity of infection of 50. After 2 and 4 h of infection, cells and bacteria were scraped from the plate, collected in 2-ml tubes, washed twice with PBS, and lysed in 100 µl of 0.1% Triton X-100 in PBS supplemented with 100 µM phenylmethylsulfonyl fluoride, 1 µg of apolipoprotein per ml, and 1 µM leupeptin. Lysates were then centrifuged for 10 min at 20,800 x g. The supernatants, corresponding to the cellular cytoplasmic fractions, were recovered and added to 25 µl of 5x Laemmli buffer. The pellet (bacteria and J774 membranes) was resuspended in 120 µl of water and 30 µl of Laemmli buffer. Both fractions were separated on SDS-12% polyacrylamide gels and analyzed by Western blotting.
Immunofluorescence experiments and invasion assay. To distinguish between intracellular and extracellular Y. enterocolitica bacteria, the double-immunofluorescence test was performed as described by Rosqvist et al. (45). S. flexneri invasion of HeLa cells was tested by the gentamicin protection assay (20). For immunofluorescence microscopy examinations, infected cells were treated as described in references 39 and 57.
Mass spectrometry (MS). (i) In-gel tryptic digestion. Stained protein bands were cut from the SDS-polyacrylamide gel and washed with high-pressure liquid chromatography-grade water. The gel was cut into 1-mm cubes, which were washed twice for 15 min with 50% acetonitrile-0.1 M ammonium bicarbonate in an Eppendorf tube. The gel pieces were then dried under vacuum. Sequencing-grade trypsin was added to the dried gel pieces (10 µl of 0.1 ng/ml in 0.1 M ammonium bicarbonate). The tube was left on ice for 20 min, then an additional 50 µl of 0.1 M ammonium bicarbonate was added, and gel pieces were incubated overnight at 30°C. The supernatant was collected in a clean Eppendorf tube, and the gel was extracted once more by adding 50 µl of 60% acetonitrile-0.1% trifluoroacetic acid. The supernatants were combined, and the volume was reduced to 1 to 2 µl under vacuum and stored at -20°C for MS analysis.
(ii) MS. Solutions from in-gel digestions were acidified with 10 µl of 0.1% trifluoroacetic acid, adsorbed on a pipette tip (ZipTip C18; Millipore), desalted by being washed with 1% acetic acid, and eluted in 4 to 6 µl of 50% acetonitrile-0.5% acetic acid. Peptides were analyzed by nanoelectrospray ionization-tandem MS (MS/MS). Briefly, 2 µl of the eluate was analyzed in an LCQ ion trap mass spectrometer (ThermoFinnigan, San Jose, Calif.) fitted with a nanoelectrospray probe (61). Spectra were taken in full MS and zoom scan mode to determine parent masses and their charge state. The source voltage was set at 0.8 kV with a scan time of 3.6 s. Selected peptides were fragmented by collision-induced dissociation to generate tandem mass spectra. The collision energy was adjusted to the minimum needed for fragmentation. For the identification of proteins, fragment masses from collision-induced mass spectra were compared by use of the computer program MS-Tag (6) to predicted spectra from protein sequence databases. If no positive identification was found, peptide sequences were derived de novo from MS/MS spectra by following the fragmentation path of y-ion series and b-ion series.
Nucleotide sequence accession number. The nucleotide sequence of the sycB-yspBCDA-acpY locus has been deposited in the GenBank nucleotide sequence database under accession number AY100449.
| RESULTS |
|---|
|
|
|---|
-helices spanning residues 348 to 376 and 429 to 447. yspC encodes a polypeptide of 382 residues with a predicted molecular mass of 48 kDa and 16% identity with IpaC. This percentage of identity increases between aa 150 and 227 to reach 25%. The transmembrane domain prediction algorithm revealed one possible transmembrane
-helix between aa 241 and 259. yspD encodes a polypeptide of 348 aa with a predicted molecular mass of 38.7 kDa, 23% identity with IpaD of S. flexneri, and 18% identity with SipD of S. enterica. Although the carboxy-terminal parts of IpaD and SipD exhibit 73% identity in comparison with the 40% global identity (24), the C-terminal part of YspD does not appear to be more conserved than the N-terminal part. yspA encodes a polypeptide of 644 aa with a predicted molecular mass of 68.7 kDa and no significant identity with IpaA or SipA. acpY encodes a polypeptide of 83 aa that presents a low similarity with acyl carrier proteins. Putative acyl carrier proteins are also encoded downstream from ipaA in S. flexneri and sipA in S. enterica. However, AcpY from Y. enterocolitica does not share any identity with Acp from S. flexneri or with IacP from S. enterica, which are themselves 31% identical.
|
Identification of the 76-, 48-, and 23-kDa proteins as YspA, YspC, and YopE, respectively. To identify proteins whose secretion was dependent on the Ysa TTS apparatus, we analyzed the five major proteins (76, 48, 46, 44, and 23 kDa) secreted by Ysa and recovered from the supernatant of Y. enterocolitica strain 8081 (Fig. 1B). The 76-kDa protein was in-gel trypsin digested, and the resulting fragments were analyzed by MS. The sequence of three peptides could be determined: a/TQVI/LD, b/I/LSAD, and c/QGTSFA, where I/L represents an indeterminate result on the mass between leucine and isoleucine. All three peptides are present in the amino acid sequence translated from yspA, corresponding to residues 103 to 107, 216 to 219, and 514 to 519, respectively. However the size of the protein (76 kDa) did not correspond to that predicted for the yspA product (69 kDa). To elucidate that point, we created a yspA mutant by integrating plasmid pPT16 into yspA. When Ysa-mediated secretion was induced in Y. enterocolitica strain 8081 yspA::pPT16, the 76-kDa band disappeared (Fig. 1B), confirming that the protein migrating at the apparent molecular mass of 76 kDa was indeed YspA.
Following trypsin digestion of the 48-kDa protein, two peptides were identified by MS: I/LNSI/L(R/K) and I/LDAI/LI/LADDTEQR, where represents an undetermined residue before the trypsin cleavage site represented by (R/K). The first peptide matched exactly the sequence of residues 427 to 430 of YspC from Y. enterocolitica strain A127/90, and the second one corresponded to residues 128 to 139 of YspC, except for the Thr instead of an Ala in position 136 that was predicted from the nucleotide sequence determined from strain A127/90. This change from Thr to Ala fits with a difference of one base (GCC to ACC) between the yspC sequences from strains 8081 and A127/90. yspC from Y. enterocolitica strain A127/90 was cloned in an expression vector, giving pBF20. The product was purified from the recombinant E. coli strain and used to immunize a rabbit. The resulting serum reacted specifically with the 48-kDa protein secreted by 8081 (Fig. 1C), confirming that this protein is YspC.
The sequences of two peptides were obtained from the analysis of the 23-kDa protein: NHDQFATGSGPLR and SGVDI/LTQAANEI/LK. The sequence of these peptides corresponds to residues 132 to 144 and 194 to 206, respectively, of the pYV-encoded YopE protein. Indeed, a polyclonal antibody raised against YopE reacted against the 23-kDa protein secreted by Y. enterocolitica strain 8081. In addition, the 23-kDa protein was absent from the culture supernatant of a derivative of Y. enterocolitica strain 8081 that had been cured of the pYV plasmid (Fig. 1C), confirming that the 23-kDa protein was indeed YopE. Under LTHS conditions, YopE was secreted through the Ysa TTS apparatus, since YopE was absent from the supernatant of the ysaN mutant carrying the pYV virulence plasmid (Fig. 1C). It is interesting that YspC, YopE, and even SycE are not produced by the ysaN mutant under LTHS conditions (Fig. 1C), indicating that there is a strong inhibition of their synthesis when the Ysa apparatus is not functional. This is particularly interesting in the case of the pYV-encoded YopE because it indicates that YopE belongs to two independent regulons.
The 46- and 44-kDa proteins were also sequenced, but the resulting peptides did not match any of the proteins encoded in the ysp locus. These proteins cannot be encoded by the pYV virulence plasmid because they were still present in the supernatant of Y. enterocolitica strain 8081 lacking the pYV plasmid (data not shown). Identification of the genes specifying these peptides is in progress.
Identification of YspD and YspB among secreted proteins. As YspD was not one of the five major proteins that were no longer secreted by the ysaN mutant, we investigated whether it could be detected by Western blot analysis of secreted proteins. YspD was purified from E. coli carrying pPT14, a recombinant plasmid encoding YspD, and used to raise a rabbit polyclonal serum. Proteins from the supernatant of a culture of Y. enterocolitica strain 8081 and of the ysaN mutant grown under LTHS conditions were analyzed by Western blotting. The anti-YspD antiserum reacted with a 38-kDa protein secreted by the wild type but not by the ysaN mutant (Fig. 1C). To confirm that this protein was encoded by yspD, we created a polar mutation by inserting the suicide plasmid pPT15 in Y. enterocolitica strain 8081. No signal was detected by Western blotting from the supernatant of this mutant (Fig. 1C). Moreover, YspA was no longer secreted by the yspD mutant, presumably as a result of the polar effect of the yspD mutation on transcription of the yspA gene (Fig. 1A and C). These results indicate that YspD was also secreted by the Ysa TTS apparatus.
Due to the instability and hydrophobicity of YspB, we could not purify this protein to raise an antibody. To investigate whether YspB was also secreted, we constructed an insertion mutation in yspB. Proteins identified as YspA (76 kDa), YspD (38 kDa), and YspC (48 kDa) were no longer secreted by the yspB mutant, presumably as a result of the polar effect of the insertion on transcription of downstream genes (Fig. 1A and B). In addition, a protein of 67 kDa was also missing in the culture supernatant of the yspB mutant, suggesting that the 67-kDa protein secreted by the wild-type strain is YspB. To further confirm this, we introduced a yspB(His)6 gene into Y. enterocolitica strain 8081 and found that the product appeared indeed as a 67-kDa protein (Fig. 1D).
In previous reports, the letter code for the Ysp proteins had been assigned according to their molecular weight (14, 63). In the Foultier et al. paper, a letter code consistent with Ipa and Sip nomenclature was introduced (11). Since the Ysp proteins are so clearly related to the Ipa and Sip proteins (see above), we continue to adopt the uniform ipa-sip nomenclature to avoid future confusion.
Attempts to deregulate Ysa secretion. A classical although not understood way to deregulate secretion by the Mxi-Spa TTSS of S. flexneri is to add Congo red to the culture medium (42). To check whether Congo red could have the same effect on Ysa, we added Congo red (3 mg/ml) to the culture of Y. enterocolitica strain 8081 and monitored the level of Ysps in the supernatant during both exponential and stationary growth phases. Congo red did not increase the level of Ysps in the culture supernatant (data not shown).
Another way to deregulate the Mxi-Spa TTSS of S. flexneri consists in inactivating ipaB or ipaD. This leads to enhanced secretion of the remaining Ipas as well as secretion of a set of about 15 other proteins (30, 42). We thus analyzed the culture supernatant of our yspB and yspD mutants. In both cases, the level of secretion of the remaining Ysp was similar to that observed with the wild-type strain, and no additional bands could be observed in an SDS-polyacrylamide gel (Fig. 1B). This suggests that regulation of secretion by the Ysa TTSS is different from that of the Mxi-Spa TTSS.
SycB binds YspB and YspC in E. coli. To analyze the ability of SycB to bind YspB and YspC as suggested by its homology with IpgC (31), we constructed plasmid pBF23 carrying a bicistronic gst-sycB yspB(His)6 ptac-dependent operon. To serve as a control, we used plasmid pBF24 encoding truncated GST-SycB1-21 and YspB-(His)6 (Fig. 2A). After 80 min of induction by IPTG, cleared extracts of E. coli were mixed either with glutathione-Sepharose beads or with an anti-GST antibody absorbed on protein A-Sepharose beads. After washing, proteins absorbed on the beads were analyzed by Western blotting. YspB-(His)6 coeluted with GST-SycB but not with GST-SycB1-21. Similarly YspB was coimmunoprecipitated with GST-SycB (Fig. 2B). This indicated that GST-SycB is able to bind specifically YspB-(His)6.
|
|
|
HOPEM, a derivative of the E40 biotype 2 strain that does not carry any ysa locus (11). When Yop secretion was induced, Y. enterocolitica
HOPEM bearing pBF17 produced both YspB-(His)6 and YspC as seen by a Western blot analysis of the crude extracts (Fig. 5A). Moreover, both YspC and YspB-(His)6 were detected in the supernatant of the culture (Fig. 5A). To know if this presence was due to Ysc-mediated secretion and not to secretion mediated by the flagellar TTS apparatus at 37°C or simply to bacterial lysis, we introduced pBF17 in the
HOPEMYscN strain. This strain lacks the YscN ATPase and is defective for Yop secretion. When secretion by the Ysc injectisome was induced, YspC and YspB-(His)6 were produced (Fig. 5A) but they were not secreted (Fig. 5A). The multicopy character of the plasmid seemed to override the feedback inhibition of pyopE due to the lack of secretion. No signal was observed in both crude extract and supernatant of the
HOPEM host bacteria, proving that the antibodies did not cross-react with Y. enterocolitica
HOPEM proteins. This showed that YspC and YspB-(His)6 are recognized as substrates for secretion by the Ysc injectisome.
|
HOPEMTinv, a strain defective in entry due to its lack of invasin (N. Grosdent et al., unpublished data). We monitored entry of
HOPEMTinv carrying pBF17 into HeLa cells by both the gentamicin protection assay and the double immunofluorescence assay. In both cases, no entry of the bacteria into HeLa cells could be observed (data not shown). Although it was not possible in the experiment to determine whether YspB and YspC were released upon contact with HeLa cells, we assumed it was the case on the basis of our in vitro secretion experiment (Fig. 5A).
YspB and YspC do not complement YopB and YopD for pore formation and effector translocation in J774 macrophages.
The facts that YspB and YspC can be secreted by the Ysc injectisome and that they are homologous to the pore-forming proteins YopB and YopD led us to investigate whether they could form pores in J774 macrophage cells. Experimentally, we monitored pore formation by the BCECF release method used by Neyt and Cornelis (37). Prior to infection, macrophages were first loaded with BCECF-AM, a membrane-permeant dye that becomes fluorescent and membrane impermeant after cleavage by intracellular esterases. As expected, BCECF was released from macrophages infected with the
HOPEM strain but not with the
HOPEMBD strain (Fig. 5B). However, when pBF15 coding for sycB, yspB, and yspC was introduced in trans into
HOPEMBD, no BCECF was released from the infected macrophages. Although it was not possible in the experiment to determine whether YspB and YspC were released upon contact with macrophages, we again assumed that it was the case on the basis of our in vitro secretion experiment (Fig. 5C). This observation suggests that, despite their homology with YopB and YopD, YspB and YspC alone are not able to form a pore when secreted by the Ysc machinery.
In addition we tested if pBF15 could complement a yopB yopD mutant of Y. enterocolitica E40 for translocation of Yop proteins. J774 cells were infected with a yopB yopD mutant bacterial strain carrying pBF15, and the injection of YopE was tested. After 2 and 4 h of infection the infected macrophages were fractionated and the cytosolic fraction was tested with an anti-YopE antibody. Although YspC was detected in the Triton-insoluble fraction, YopE was not recovered in the cytosolic fraction, indicating that pBF15 could not complement the yopB yopD mutation (data not shown). In addition, macrophages did not undergo apoptosis, indicating that YopP was not injected (data not shown).
Complementation of S. flexneri mutants. To investigate if the function of SycB, YspB, and YspC was conserved during evolution, we tried to complement a series of S. flexneri mutants defective in the corresponding homologs. IpgC is required for the stability of IpaB in the cytoplasm of S. flexneri (31), and inactivation of ipgC results in a decreased amount of IpaB (Fig. 6A). To test whether SycB could replace IpgC in its role of chaperone for IpaB, plasmid pBF25, which constitutively expresses sycB from a lac promoter, was introduced into the S. flexneri strain RM97 (ipgC). We analyzed IpaB in the supernatant of S. flexneri bacteria after induction of Mxi-Spa secretion. There was no difference in the IpaB content between the supernatant of ipgC mutant bacteria and the supernatant of ipgC plac-sycB+ bacteria (Fig. 6A). Production of SycB from pBF25 in the ipgC mutant bacteria was detectable by SDS-PAGE and Coomassie blue staining (data not shown), but the presence of SycB did not result in an increased production of IpaB, indicating that SycB could not act as a chaperone for IpaB (Fig. 6A). In addition to its role as a chaperone for IpaB and IpaC, IpgC acts as a coactivator of MxiE, the transcriptional activator involved in expression of genes that are regulated by the activity of the Mxi-Spa TTS apparatus (28). These genes include members of the ipaH family, which are expressed in an ipaB mutant as a consequence of the deregulated activity of the Mxi-Spa apparatus (10). In contrast to an ipaB mutant, an ipaB ipgC mutant produces little IpaH (Fig. 6B). Expression of SycB in the ipaB ipgC mutant did not restore production of IpaH proteins, indicating that SycB could not act as a coactivator for MxiE.
|
Inactivation of the ipaC gene is associated with a defect in entry into nonphagocytic cells (32). We introduced plasmid pBF29, which constitutively expresses both sycB and yspC, into S. flexneri RM81 (ipaC). The defect in entry of the ipaC mutant was not complemented by YspC as monitored by a gentamicin protection assay and immunofluorescence microscopy (data not shown). Since this result could be the consequence of a lack of secretion of YspC, we analyzed by Western blotting the supernatant of S. flexneri RM81(pBF29) grown for 4 h of culture in tryptic soy broth at 37°C. YspC was recovered when secretion was induced by addition of Congo red (Fig. 6D). The polyclonal anti-YspC antibody did not cross-react with proteins secreted by S. flexneri, because no signal was observed in the supernatant of S. flexneri RM81 (Fig. 6D). We conclude from this experiment that, even if YspC is recognized as a substrate for the Mxi-Spa apparatus, it does not promote invasion of eukaryotic cells. This can be explained in two ways: either YspC does not interact with the other proteins of the entry complex or it is not secreted in sufficient amounts. However, one cannot rule out the possibility that YspC is not linked to cell invasion.
| DISCUSSION |
|---|
|
|
|---|
The sequence of peptides from the third secreted protein that is not encoded in the ysa locus exactly matched internal sequences of the pYV-encoded YopE protein, and an anti-YopE polyclonal antibody reacted with the protein. Moreover this protein was no longer present in the supernatant of bacteria lacking the pYV plasmid, demonstrating unambiguously that this protein is YopE, the pYV-encoded GTPase-activating protein which was first characterized as a substrate of the Ysc TTSS (34). However, under LTHS conditions YopE secretion did not occur through the Ysc machinery, since YopE was not present in the supernatant of ysaN mutant bacteria still possessing the pYV plasmid and grown under LTHS conditions. This result is in perfect agreement with the results of Young and Young that appeared while this paper was under revision showing that the Ysa system secretes Yop proteins (62). We speculate that, under in vivo infection, Ysa also recruits YopE. This is reminiscent of the S. enterica SspH1 protein, which is secreted by both SPI-1- and SPI-2-encoded TTSSs (33). To understand this recruitment, it will be interesting to determine whether secretion of YopE under LTHS conditions requires VirF or another, as yet unknown, transcription activator. Since Ysa is present only in biotype 1B strains, it would be interesting to study the expression of YopE under LTHS conditions, comparing strains from biotype 1B to strains from the low-virulence biotypes. The recruitment of YopE by Ysa also raises the question of the physiological significance of this dual role. Indeed the YspB and YspD proteins resemble the invasion-promoting IpaB and IpaD or SipB and SipD, while YopE has an anti-internalization activity. This does not seem to be consistent unless the YspB and YspD proteins are not invasion-promoting proteins, as suggested by our cell invasion experiments. Alternatively, YopE could play in this context a role different from its anti-internalization one. Answers to these questions will probably await some progress in the identification of the target organism or cell for the Ysa system. Secretion of Yop proteins by the Ysa system represents a new example of the promiscuity of TTS effectors in Yersinia. In addition, we demonstrate that YspB and YspC can also be secreted via the Ysc TTSS. To complete the picture, it should be remembered that YplA, a protein secreted by the flagellar TTS apparatus of Yersinia, could also be secreted by Ysc and Ysa TTSSs (63).
Because of their putative transmembrane structure, YspB and YspC could interact with the eukaryotic cell membrane and behave as translocators for other secreted proteins such as YspD, YspA, and YopE (8). However, the type of contact that induces secretion by the Ysa system is still not known. In order to investigate the role of YspB and YspC in contact with eukaryotic cells, we took advantage of the fact that they can be secreted via the Ysc apparatus, and we tested whether they could complement YopB and YopD for pore-forming and effector translocation activity. YspB and YspC did not complement YopB and YopD, suggesting either that they are not pore formers or that they are not in the appropriate amount or conformation when secreted by the Ysc apparatus. By analogy with the Shigella and Salmonella systems, we also tested whether YspB and YspC secreted by the Ysc apparatus could promote entry into eukaryotic cells. This hypothesis was tested with an invasin-negative Y. enterocolitica strain, but again no conclusive result was obtained. However, this does not rule out the possibility that YspB and YspC are part of an entry mechanism, because other proteins encoded by this operon could be involved in the process. This could be solved by expressing the whole sycB-yspBCDA-acpY operon downstream from the yopE promoter. Addressing this question would presumably shed some light on the role of the second TTSS in Y. enterocolitica.
The last open reading frame identified was called acpY. AcpY resembles acyl carrier proteins involved in the biosynthesis of fatty acid chains. Interestingly, the activation step of toxins from the RTX family is accomplished by fatty acid acylation and requires the participation of an acyl carrier protein. Acyl groups are key elements in the attachment of an RTX toxin to the cell membrane (21, 54). When the biological function of Ysa is understood, it will be worthwhile testing the effect of a mutation in acpY on this function.
In consideration of the small size of SycB, its acidic pI, and its similarity to IpgC and SicA, there was a strong presumption that it might constitute a chaperone for YspB and YspC. By using a GST pull-down assay and coimmunoprecipitation experiments, we demonstrated that indeed SycB belongs in the family of bimodular TTS chaperones, which include IpgC, the chaperone of IpaB and IpaC from S. flexneri (29, 58); SicA (SipB and SipC) from S. enterica (16, 24); SycD (YopB and YopD) from Y. enterocolitica (38); and PcrH (PopB and PopD) from Pseudomonas aeruginosa (12). The role of these chaperones could be to maintain their substrates in a stable or TTS-competent state, to prevent cytoplasmic interaction between the two secreted partners, and to protect the bacterium from membrane toxicity (31, 38, 55). Our results demonstrate the validity of the third hypothesis, without ruling out the others.
| ACKNOWLEDGMENTS |
|---|
HOPEMTinv, C. Neyt for the gift of Y. enterocolitica
HOPEMBD, and M. P. Sory for construction of Y. enterocolitica
HOPEMTYscN. P.T. and M.-N.M. are funded by the Belgian "Fond pour la formation à la Recherche dans l'Industrie et dans l'Agriculture (FRIA)." This work was supported by the Belgian "Fonds National de la Recherche Scientifique Médicale" (Convention 3.4595.97), by the "Direction générale de la Recherche Scientifique Communauté Française de Belgique" (Action de Recherche concertée 99/04-236), by the EU TMR network (FMRX-CT98-0164), and by the Swiss National Science Foundation (grant 32-65393.1).
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Bernardini, M. L., J. Mounier, H. d'Hauteville, M. Coquis-Rondon, and P. J. Sansonetti. 1989. Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin. Proc. Natl. Acad. Sci. USA 86:3867-3871. |
| 2. | Boland, A., and G. R. Cornelis. 1998. Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection. Infect. Immun. 66:1878-1884. |
| 3. | Buchrieser, C., P. Glaser, C. Rusniok, H. Nedjari, H. D'Hauteville, F. Kunst, P. Sansonetti, and C. Parsot. 2000. The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri. Mol. Microbiol. 38:760-771.[CrossRef][Medline] |
| 4. | Carniel, E., I. Guilvout, and M. Prentice. 1996. Characterization of a large chromosomal "high-pathogenicity island" in biotype 1B Yersinia enterocolitica. J. Bacteriol. 178:6743-6751. |
| 5. | Chen, Y., M. R. Smith, K. Thirumalai, and A. Zychlinsky. 1996. A bacterial invasin induces macrophage apoptosis by binding directly to ICE. EMBO J. 15:3853-3860.[Medline] |
| 6. | Clauser, K. R., P. Baker, and A. L. Burlingame. 1999. Role of accurate mass measurement (± 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Anal. Chem. 71:2871-2882.[Medline] |
| 7. | Cornelis, G., Y. Laroche, G. Balligand, M. P. Sory, and G. Wauters. 1987. Yersinia enterocolitica, a primary model for bacterial invasiveness. Rev. Infect. Dis. 9:64-87.[Medline] |
| 8. | Cornelis, G. R., and H. Wolf-Watz. 1997. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol. Microbiol. 23:861-867.[CrossRef][Medline] |
| 9. | Cover, T. L., and R. C. Aber. 1989. Yersinia enterocolitica. N. Engl. J. Med. 321:16-24.[Medline] |
| 10. | Demers, B., P. J. Sansonetti, and C. Parsot. 1998. Induction of type III secretion in Shigella flexneri is associated with differential control of transcription of genes encoding secreted proteins. EMBO J. 17:2894-2903.[CrossRef][Medline] |
| 11. | Foultier, B., P. Troisfontaines, S. Müller, F. R. Opperdoes, and G. R. Cornelis. 2002. Characterization of the ysa pathogenicity locus in the chromosome of Yersinia enterocolitica and phylogeny analysis of type III secretion systems. J. Mol. Evol. 55:37-51.[CrossRef][Medline] |
| 12. | Frithz-Lindsten, E., A. Holmstrom, L. Jacobsson, M. Soltani, J. Olsson, R. Rosqvist, and A. Forsberg. 1998. Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis. Mol. Microbiol. 29:1155-1165.[CrossRef][Medline] |
| 13. | Grutzkau, A., C. Hanski, H. Hahn, and E. O. Riecken. 1990. Involvement of M cells in the bacterial invasion of Peyer's patches: a common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria. Gut 31:1011-1015. |
| 14. | Haller, J. C., S. Carlson, K. J. Pederson, and D. E. Pierson. 2000. A chromosomally encoded type III secretion pathway in Yersinia enterocolitica is important in virulence. Mol. Microbiol. 36:1436-1446.[CrossRef][Medline] |
| 15. | Hanski, C., U. Kutschka, H. P. Schmoranzer, M. Naumann, A. Stallmach, H. Hahn, H. Menge, and E. O. Riecken. 1989. Immunohistochemical and electron microscopic study of interaction of Yersinia enterocolitica serotype O8 with intestinal mucosa during experimental enteritis. Infect. Immun. 57:673-678. |
| 16. | Hermant, D., R. Menard, N. Arricau, C. Parsot, and M. Y. Popoff. 1995. Functional conservation of the Salmonella and Shigella effectors of entry into epithelial cells. Mol. Microbiol. 17:781-789.[CrossRef][Medline] |
| 17. | High, N., J. Mounier, M. C. Prevost, and P. J. Sansonetti. 1992. IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole. EMBO J. 11:1991-1999.[Medline] |
| 18. | Ichinohe, H., M. Yoshioka, H. Fukushima, S. Kaneko, and T. Maruyama. 1991. First isolation of Yersinia enterocolitica serotype O:8 in Japan. J. Clin. Microbiol. 29:846-847. |
| 19. | Iriarte, M., and G. R. Cornelis. 1998. YopT, a new Yersinia Yop effector protein, affects the cytoskeleton of host cells. Mol. Microbiol. 29:915-929.[CrossRef][Medline] |
| 20. | Isberg, R. R., and S. Falkow. 1985. A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature 317:262-264.[CrossRef][Medline] |
| 21. | Issartel, J. P., V. Koronakis, and C. Hughes. 1991. Activation of Escherichia coli prohaemolysin to the mature toxin by acyl carrier protein-dependent fatty acylation. Nature 351:759-761.[CrossRef][Medline] |
| 22. | Kaneko, S., and T. Maruyama. 1987. Pathogenicity of Yersinia enterocolitica serotype O3 biotype 3 strains. J. Clin. Microbiol. 25:454-455. |
| 23. | Kaniga, K., I. Delor, and G. R. Cornelis. 1991. A wide-host-range suicide vector for improving reverse genetics in gram-negative bacteria: inactivation of the blaA gene of Yersinia enterocolitica. Gene 109:137-141.[CrossRef][Medline] |
| 24. | Kaniga, K., S. Tucker, D. Trollinger, and J. E. Galan. 1995. Homologs of the Shigella IpaB and IpaC invasins are required for Salmonella typhimurium entry into cultured epithelial cells. J. Bacteriol. 177:3965-3971. |
| 25. | Lafleur, L., O. Hammerberg, G. Delage, and C. H. Pai. 1979. Yersinia enterocolitica infection in children: 4 years experience in the Montreal urban community. Contrib. Microbiol. Immunol. 5:298-303.[Medline] |
| 26. | Makino, S., C. Sasakawa, K. Kamata, T. Kurata, and M. Yoshikawa. 1986. A genetic determinant required for continuous reinfection of adjacent cells on large plasmid in S. flexneri 2a. Cell 46:551-555.[CrossRef][Medline] |
| 27. | Marjai, E., M. Kalman, I. Kajary, A. Belteky, and M. Rodler. 1987. Isolation from food and characterization by virulence tests of Yersinia enterocolitica associated with an outbreak. Acta Microbiol. Hung. 34:97-109.[Medline] |
| 28. | Mavris, M., A. L. Page, R. Tournebize, B. Demers, P. Sansonetti, and C. Parsot. 2002. Regulation of transcription by the activity of the Shigella flexneri type III secretion apparatus. Mol. Microbiol. 43:1543-1553.[CrossRef][Medline] |
| 29. | Menard, R., M. C. Prevost, P. Gounon, P. Sansonetti, and C. Dehio. 1996. The secreted Ipa complex of Shigella flexneri promotes entry into mammalian cells. Proc. Natl. Acad. Sci. USA 93:1254-1258. |
| 30. | Menard, R., P. Sansonetti, and C. Parsot. 1994. The secretion of the Shigella flexneri Ipa invasins is activated by epithelial cells and controlled by IpaB and IpaD. EMBO J. 13:5293-5302.[Medline] |
| 31. | Menard, R., P. Sansonetti, C. Parsot, and T. Vasselon. 1994. Extracellular association and cytoplasmic partitioning of the IpaB and IpaC invasins of S. flexneri. Cell 79:515-525.[CrossRef][Medline] |
| 32. | Menard, R., P. J. Sansonetti, and C. Parsot. 1993. Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J. Bacteriol. 175:5899-5906. |
| 33. | Miao, E. A., C. A. Scherer, R. M. Tsolis, R. A. Kingsley, L. G. Adams, A. J. Baumler, and S. I. Miller. 1999. Salmonella typhimurium leucine-rich repeat proteins are targeted to the SPI1 and SPI2 type III secretion systems. Mol. Microbiol. 34:850-864.[CrossRef][Medline] |
| 34. | Michiels, T., P. Wattiau, R. Brasseur, J. M. Ruysschaert, and G. Cornelis. 1990. Secretion of Yop proteins by yersiniae. Infect. Immun. 58:2840-2849. |
| 35. | Mills, S. D., A. Boland, M. P. Sory, P. van der Smissen, C. Kerbourch, B. B. Finlay, and G. R. Cornelis. 1997. Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein. Proc. Natl. Acad. Sci. USA 94:12638-12643. |
| 36. | Mirold, S., W. Rabsch, M. Rohde, S. Stender, H. Tschape, H. Russmann, E. Igwe, and W. D. Hardt. 1999. Isolation of a temperate bacteriophage encoding the type III effector protein SopE from an epidemic Salmonella typhimurium strain. Proc. Natl. Acad. Sci. USA 96:9845-9850. |
| 37. | Neyt, C., and G. Cornelis. 1999. Insertion of a Yop translocation pore into the macrophage plasma membrane by Yersinia enterocolitica: requirement for translocators YopB and YopD, but not LcrG. Mol. Microbiol. 33:971-981.[CrossRef][Medline] |
| 38. | Neyt, C., and G. R. Cornelis. 1999. Role of SycD, the chaperone of the Yersinia Yop translocators YopB and YopD. Mol. Microbiol. 31:143-156.[CrossRef][Medline] |
| 39. | Nhieu, G. T., and P. J. Sansonetti. 1999. Mechanism of Shigella entry into epithelial cells. Curr. Opin. Microbiol. 2:51-55.[CrossRef][Medline] |
| 40. | Page, A. L., H. Ohayon, P. J. Sansonetti, and C. Parsot. 1999. The secreted IpaB and IpaC invasins and their cytoplasmic chaperone IpgC are required for intercellular dissemination of Shigella flexneri. Cell. Microbiol. 1:183-193.[CrossRef][Medline] |
| 41. | Page, A. L., P. Sansonetti, and C. Parsot. 2002. Spa15 of Shigella flexneri, a third type of chaperone in the type III secretion pathway. Mol. Microbiol. 43:1533-1542.[CrossRef][Medline] |
| 42. | Parsot, C., R. Menard, P. Gounon, and P. J. Sansonetti. 1995. Enhanced secretion through the Shigella flexneri Mxi-Spa translocon leads to assembly of extracellular proteins into macromolecular structures. Mol. Microbiol. 16:291-300.[Medline] |
| 43. | Portnoy, D. A., S. L. Moseley, and S. Falkow. 1981. Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis. Infect. Immun. 31:775-782. |
| 44. | Rakin, A., C. Noelting, S. Schubert, and J. Heesemann. 1999. Common and specific characteristics of the high-pathogenicity island of Yersinia enterocolitica. Infect. Immun. 67:5265-5274. |
| 45. | Rosqvist, R., I. Bolin, and H. Wolf-Watz. 1988. Inhibition of phagocytosis in Yersinia pseudotuberculosis: a virulence plasmid-encoded ability involving the Yop2b protein. Infect. Immun. 56:2139-2143. |
| 46. | Sansonetti, P. J., J. Arondel, J. R. Cantey, M. C. Prevost, and M. Huerre. 1996. Infection of rabbit Peyer's patches by Shigella flexneri: effect of adhesive or invasive bacterial phenotypes on follicle-associated epithelium. Infect. Immun. 64:2752-2764.[Abstract] |
| 47. | Sansonetti, P. J., D. J. Kopecko, and S. B. Formal. 1982. Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect. Immun. 35:852-860. |